These agents may also inhibit neutrophil migration—an important mechanism given that tumour cells can exploit neutrophil adhesion, mediated by intercellular adhesion molecule-1 (ICAM-1), to traverse the endothelium more easily [11]. The gene discussed is ICAM1; the disease is neoplasm.